Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis
- 1 September 1990
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 117 (3), 482-489
- https://doi.org/10.1016/s0022-3476(05)81103-5
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Liver Disease and Common-Bile-Duct Stenosis in Cystic FibrosisNew England Journal of Medicine, 1988
- Pattern recognition study of biochemical assays for liver functionAnalytica Chimica Acta, 1987
- Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acidsMedical Hypotheses, 1986
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985
- Development of a sensitive enzyme immunoassay for plasma and salivary steroidsTalanta, 1984
- Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosisDigestive Diseases and Sciences, 1983
- Hepatobiliary Disease in Cystic FibrosisJournal of Pediatric Gastroenterology and Nutrition, 1982
- The Effect of Tauroursodeoxycholic Acid and Taurine Supplementation on Biliary Bile Acid CompositionHepatology, 1982
- Production of a high-titer antibody to bile acidsThe Journal of Steroid Biochemistry and Molecular Biology, 1980
- Cystic fibrosis in adults: 75 cases and a review of 232 cases in the literatureThe American Journal of Medicine, 1979